Clinical case of clavulanate allergy in a patient with suppurative hidradenitis

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Beta-lactam antibiotics include several major groups of drugs that share structural similarities and mechanisms of action and often are first-line therapies for various bacterial infections.

In clinical practice all groups of beta-lactam antibiotics are frequently excluded from treatment in case of adverse reactions associated with their use. However, allergic reactions typically develop via sensitization to specific antigenic determinants, rather than to the beta-lactam ring. Therefore, stepwise and thorough allergological evaluation is necessary to accurately define the spectrum of drug hypersensitivity.

This article describes the structural characteristics of beta-lactam antibacterial agents and their cross-reactivity, along with key information on types of reactions associated with clavulanate. A clinical case of clavulanate allergy is presented.

The diagnostic approach included a stepwise drug testing performed with ceftriaxone, cefixime, amoxicillin/clavulanate, ampicillin and amoxicillin. Immediate-type allergy to clavulanate was confirmed and no cross-reactivity to other beta-lactam antibiotics was discovered. According to personalized recommendations given to the patient, only beta-lactam antibiotics containing clavulanate were contraindicated, rather than the entire class of beta-lactams.

About the authors

Tatiana V. Nekrasova

National Research Center — Institute of Immunology Federal Medical-Biological Agency

Author for correspondence.
Email: loriley@mail.ru
ORCID iD: 0009-0002-4837-6624
SPIN-code: 8290-3584
Russian Federation, Moscow

Elena A. Latysheva

National Research Center — Institute of Immunology Federal Medical-Biological Agency

Email: ealat@mail.ru
ORCID iD: 0000-0002-1606-205X
SPIN-code: 2063-7973

MD, Dr. Sci. (Medicine)

Russian Federation, Moscow

Tatiana N. Myasnikova

National Research Center — Institute of Immunology Federal Medical-Biological Agency

Email: t_miasnikova@mail.ru
ORCID iD: 0000-0001-8491-195X
SPIN-code: 4684-3112

MD, Dr. Sci. (Medicine)

Russian Federation, Moscow

References

  1. Shah NS, Ridgway JP, Pettit N, et al. Documenting penicillin allergy: the impact of inconsistency. PLoS One. 2016;11(3):e0150514. doi: 10.1371/journal.pone.0150514
  2. Mak HWF, Yeung MHY, Wong JCY, et al. Differences in beta-lactam and penicillin allergy: beyond the West and focusing on Asia-Pacific. Front Allergy. 2022;3:1059321. doi: 10.3389/falgy.2022.1059321 EDN: FEGIVZ
  3. Torres-Rojas I, Pérez-Alzate D, Somoza ML, et al. Clavulanic acid is a leading culprit beta-lactam in immediate allergic reactions to penicillins. Allergy Asthma Immunol Res. 2023;15(2):201–213. doi: 10.4168/aair.2023.15.2.201 EDN: CHKGQA
  4. Barbero N, Fernández-Santamaría R, Mayorga C, et al. Identification of an antigenic determinant of clavulanic acid responsible for IgE-mediated reactions. Allergy. 2019;74(8):1490–1501. doi: 10.1111/all.13761
  5. Ильина Н И, Латышева Т В, Мясникова Т Н, Романова Т С. Проект методических рекомендаций по диагностике лекарственной аллергии. Режим доступа: https://raaci.ru/dat/pdf/KR/project_lek_2022.pdf Дата обращения: 06.07.2025.
  6. Torres MJ, Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am. 2010;94(4):805–820, xii. doi: 10.1016/j.mcna.2010.04.006
  7. Berasategui AMT, Morales PO, Niso MG. Allergy to beta-lactams: myths, realities and novelties. Nat Cell Sci. 2024;2(2):74–84. doi: 10.61474/ncs.2023.00034
  8. Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. Lancet. 2019;393(10167):183–198. doi: 10.1016/S0140-6736(18)32218-9
  9. Zagursky RJ, Pichichero ME. Cross-reactivity in β-lactam allergy. J Allergy Clin Immunol Pract. 2018;6(1):72–81.e1. doi: 10.1016/j.jaip.2017.08.027
  10. Blanca-Lopez N, Perez-Alzate D, Ruano F, et al. Selective immediate responders to amoxicillin and clavulanic acid tolerate penicillin derivative administration after confirming the diagnosis. Allergy. 2015;70(8):1013–1019. doi: 10.1111/all.12636
  11. Kulhas Celik I, Guvenir H, Hurmuzlu S, et al. The negative predictive value of 5-day drug provocation test in nonimmediate beta-lactam allergy in children. Ann Allergy Asthma Immunol. 2020;124(5):494–499. doi: 10.1016/j.anai.2019.12.029 EDN: MMOYUC
  12. Freundt-Serpa NP, Salas-Cassinello M, Gonzalo-Fernández A, et al. Deconstructing adverse reactions to amoxicillin-clavulanic acid: the importance of time of onset. J Investig Allergol Clin Immunol. 2024;34(3):177–187. doi: 10.18176/jiaci.0896 EDN: SYIKRS
  13. Romano A, Gaeta F, Valluzzi RL, et al. Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins. Allergy. 2014;69(6):806–809. doi: 10.1111/all.12390
  14. Salas M, Fernández-Santamaría R, Mayorga C, et al. Use of the basophil activation test may reduce the need for drug provocation in amoxicillin-clavulanic allergy. J Allergy Clin Immunol Pract. 2018;6(3):1010–1018.e2. doi: 10.1016/j.jaip.2017.08.009
  15. Labella M, Rodriguez de Guzmán J, Diez-Echave P, et al. Direct single-dose drug-provocation test is safe for delabelling penicillin low-risk reactions in adults. Allergy. 2025;80(11):3127–3139. doi: 10.1111/all.16567 EDN: QQBOWB
  16. Rivolta F, Cappelletti C, Sangalli A, et al. Clavulanic acid sensitization seems more involved in cutaneous than systemic reactions in amoxicillin clavulanate drug reactions. Eur Ann Allergy Clin Immunol. 2025;57(2):83–87. doi: 10.23822/EurAnnACI.1764-1489.329 EDN: XJNXKN

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © ABV-press, 2026

License URL: https://rusalljournal.ru/raj/about/submissions#copyrightNotice

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-42773 от  21.07.2009.